463 related articles for article (PubMed ID: 28505592)
1. Human norovirus inhibition by a human milk oligosaccharide.
Koromyslova A; Tripathi S; Morozov V; Schroten H; Hansman GS
Virology; 2017 Aug; 508():81-89. PubMed ID: 28505592
[TBL] [Abstract][Full Text] [Related]
2. Structural Basis for Norovirus Inhibition by Human Milk Oligosaccharides.
Weichert S; Koromyslova A; Singh BK; Hansman S; Jennewein S; Schroten H; Hansman GS
J Virol; 2016 May; 90(9):4843-4848. PubMed ID: 26889023
[TBL] [Abstract][Full Text] [Related]
3. Human Norovirus Interactions with Histo-Blood Group Antigens and Human Milk Oligosaccharides.
Schroten H; Hanisch FG; Hansman GS
J Virol; 2016 Jul; 90(13):5855-5859. PubMed ID: 27122582
[TBL] [Abstract][Full Text] [Related]
4. Strain-specific interaction of a GII.10 Norovirus with HBGAs.
Jin M; Tan M; Xia M; Wei C; Huang P; Wang L; Zhong W; Duan Z; Jiang X
Virology; 2015 Feb; 476():386-394. PubMed ID: 25591173
[TBL] [Abstract][Full Text] [Related]
5. Human noroviruses' fondness for histo-blood group antigens.
Singh BK; Leuthold MM; Hansman GS
J Virol; 2015 Feb; 89(4):2024-40. PubMed ID: 25428879
[TBL] [Abstract][Full Text] [Related]
6. Biotechnologically produced fucosylated oligosaccharides inhibit the binding of human noroviruses to their natural receptors.
Derya SM; Spiegel H; Hanisch FG; Morozov V; Schroten H; Jennewein S; Parschat K
J Biotechnol; 2020 Jul; 318():31-38. PubMed ID: 32387450
[TBL] [Abstract][Full Text] [Related]
7. Structural Basis of Nanobodies Targeting the Prototype Norovirus.
Ruoff K; Kilic T; Devant J; Koromyslova A; Ringel A; Hempelmann A; Geiss C; Graf J; Haas M; Roggenbach I; Hansman G
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602609
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability.
Hansman GS; Biertümpfel C; Georgiev I; McLellan JS; Chen L; Zhou T; Katayama K; Kwong PD
J Virol; 2011 Jul; 85(13):6687-701. PubMed ID: 21525337
[TBL] [Abstract][Full Text] [Related]
9. Direct Blockade of the Norovirus Histo-Blood Group Antigen Binding Pocket by Nanobodies.
Kher G; Sabin C; Lun JH; Devant JM; Ruoff K; Koromyslova AD; von Itzstein M; Pancera M; Hansman GS
J Virol; 2023 Apr; 97(4):e0183322. PubMed ID: 36971561
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of histo-blood group antigen binding as a novel strategy to block norovirus infections.
Zhang XF; Tan M; Chhabra M; Dai YC; Meller J; Jiang X
PLoS One; 2013; 8(7):e69379. PubMed ID: 23894462
[TBL] [Abstract][Full Text] [Related]
11. Human Noroviruses Attach to Intestinal Tissues of a Broad Range of Animal Species.
Villabruna N; Schapendonk CME; Aron GI; Koopmans MPG; de Graaf M
J Virol; 2021 Jan; 95(3):. PubMed ID: 33115870
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic cleavage promotes disassembly of GII.3 norovirus virus like particles and its binding to salivary histo-blood group antigens.
Huo Y; Wang W; Zheng L; Chen X; Shen S; Wang M
Virus Res; 2017 Aug; 240():18-24. PubMed ID: 28754559
[TBL] [Abstract][Full Text] [Related]
13. Genogroup IV and VI canine noroviruses interact with histo-blood group antigens.
Caddy S; Breiman A; le Pendu J; Goodfellow I
J Virol; 2014 Sep; 88(18):10377-91. PubMed ID: 25008923
[TBL] [Abstract][Full Text] [Related]
14. Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008.
Yang Y; Xia M; Tan M; Huang P; Zhong W; Pang XL; Lee BE; Meller J; Wang T; Jiang X
J Virol; 2010 Sep; 84(18):9595-607. PubMed ID: 20592096
[TBL] [Abstract][Full Text] [Related]
15. Chimeric GII.3/GII.6 norovirus capsid (VP1) proteins: characterization by electron microscopy, trypsin sensitivity and binding to histo-blood group antigens.
Ma S; Zheng L; Liu J; Wang W; Ma J; Cheng X; Ge L; Wang M; Huo Y; Shen S
Arch Virol; 2018 Dec; 163(12):3265-3273. PubMed ID: 30143876
[TBL] [Abstract][Full Text] [Related]
16. [Analyses of Binding Profiles of the GII. 12 Norovirus with Human Histo-blood Group Antigens].
Jin M; Chen K; Song J; Li H; Zhang Q; Kong X; Liu N; Duan Z
Bing Du Xue Bao; 2015 Mar; 31(2):164-9. PubMed ID: 26164942
[TBL] [Abstract][Full Text] [Related]
17. Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket.
Koromyslova AD; Morozov VA; Hefele L; Hansman GS
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541855
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of host ligand specificity change of GII porcine noroviruses from their closely related GII human noroviruses.
Yang Y; Xia M; Wang L; Arumugam S; Wang Y; Ou X; Wang C; Jiang X; Tan M; Chen Y; Li X
Emerg Microbes Infect; 2019; 8(1):1642-1657. PubMed ID: 31711377
[TBL] [Abstract][Full Text] [Related]
19. Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability.
Huo Y; Wang W; Ling T; Wan X; Ding L; Shen S; Huo J; Zhang S; Wang M; Wang Y; Liu Y
Virus Res; 2016 Sep; 224():1-5. PubMed ID: 27521750
[TBL] [Abstract][Full Text] [Related]
20. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns.
Huang P; Farkas T; Zhong W; Tan M; Thornton S; Morrow AL; Jiang X
J Virol; 2005 Jun; 79(11):6714-22. PubMed ID: 15890909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
